Objectives. Innate immune responses in the rheumatoid synovium contribute to inflammation and joint destruction in RA. Two IkB kinase (IKK)-related kinases, TNF receptor associated factor (TRAF) family member-associated nuclear factor k-light-chain enhancer of activated B cells (NF-kB) activator (TANK)-binding kinase 1 (TBK1) and IKKe, potentially regulate synovitis by activating IFN response genes. These kinases induce the expression of inflammatory mediators such as C-X-C motif ligand 10 (CXCL10)/IFN-ginduced protein 10 kDa (IP-10) in fibroblast-like synoviocytes (FLS). Since IP-10 is a promising therapeutic target in RA, we evaluated whether blocking TBK1 might be an effective way to modulate IP-10 expression.
Introduction
RA is a systemic immune-mediated disease characterized by chronic synovial inflammation and joint destruction [13] . Although adaptive immune responses contribute to many aspects of the disease, innate immunity and Toll-like receptors (TLRs) have been implicated in its initiation and perpetuation [4, 5] . Regulation of the IFN signature by TLR3 is particularly interesting because expression of the receptor is elevated in RA synovial lining, primarily in fibroblast-like synoviocytes (FLS) [6, 7] . Nuclear components from damaged synovial tissue activate the TLR3 pathway in FLS [8] , inducing the production of metalloproteinases, cytokines and chemokines that contribute to synovitis and matrix destruction [911] .
The binding of dsRNA or its mimetic, polyinosinic acid : polycytidylic acid [poly(I:C)], to endosomal TLR3 activates the IFN-response pathway in FLS [12] . TLR3 dimerization leads to the phosphorylation of two IkB kinase (IKK)-related kinases, IKKe and TNF receptor associated factor (TRAF) family member-associated nuclear factor k-light-chain enhancer of activated B cells (NF-kB) activator (TANK)-binding kinase 1 (TBK1) [1315] . These kinases, in turn, phosphorylate IFN regulatory factors (IRFs) 3 and 7, transcription factors that induce the expression of IFN response genes. IKKe and TBK1 contribute to chronic inflammation by regulating production of pro-inflammatory mediators such as C-X-C motif ligand 10 (CXCL10)/IFN-g-induced protein 10 kDa (IP-10) (16, 17) .
A recent clinical trial has demonstrated the efficacy of anti-IP-10 neutralizing antibody in RA and ulcerative colitis [18, 19] . A potential alternative to a biologic that blocks IP-10 is a small molecule inhibitor that targets components of the IKK-related kinase pathway. Both IKKe and TBK1 are possible targets that regulate this chemokine, but their functional hierarchy is not known in FLS, which are the primary producers of IP-10 in the synovium. In this study, we evaluated the effects of TBK1 and IKKe deficiency in poly(I:C)-stimulated FLS. The data suggest that TBK1 would be the optimal target for modulating IP-10 production.
Materials and methods

Reagents
Polyinosinic acid : polycytidylic acid [poly(I:C)] and anti-bactin antibody were obtained from Sigma (St Louis, MO, USA). Anti-mouse IRF3 antibody was purchased from Invitrogen (Carlsbad, CA, USA). Anti-TBK1 antibody was purchased from Epitomics (San Diego, CA, USA). Actinomycin D was purchased from USB Corporation (Cleveland, OH, USA).
Mice
IKKe
À/À (C57/b6) mice were derived from breeding pairs purchased from Dr Tom Maniatis (Harvard University, Cambridge, MA, USA). Wild-type (WT) mice (C57/b6) were purchased from Charles River Laboratories (Wilmington, MA, USA). All experimental protocols involving animals were reviewed and approved by the University of California San Diego Institutional Animal Care and Use Committee (IACUC; La Jolla, CA, USA).
FLS and culture conditions
Synovia from IKKe À/À and WT mice were micro-dissected from ankles, minced and digested with 1 mg/ml collagenase in serum-free Roswell Park Memorial Institute medium for 2 h at 37 C. The cell suspension was washed extensively and cultured in complete Dulbecco's modified Eagle medium (DMEM) [supplemented with 10% fetal bovine serum (FBS), penicillin, streptomycin, gentamicin and L-glutamine] in a humidified 5% CO 2 atmosphere. After overnight culture, non-adherent cells were removed and adherent cells were cultivated in 10% FBS/DMEM. At confluence, cells were trypsinized and split at a 1 : 3 ratio. FLS were used from passages 34 at 90% confluence. Cells were synchronized in 0.1% FBS/DMEM for 18 h before addition of poly(I:C) [20, 21] . 
Cytokine analysis
Cytokine gene expression was measured by quantitative real-time PCR using the GeneAmp 7300 sequence detection system (Applied Biosystems, Foster City, CA, USA) as previously described [22] . The C t values were normalized to Hypoxanthine-guanine phosphoribosyltransferase1 (HPRT1) expression. Cytokines in cell supernatants were quantified using murine multiplex assays (Bio-Rad, Hercules, CA, USA).
Nuclear extract preparation and native PAGE Nuclear extracts were obtained using the nuclear extraction kit (Panomics, Fremont, CA, USA), according to the manufacturer's instruction. The protein concentration was measured using DC protein assay (Bio-Rad, Hercules, CA, USA). For detecting IRF3 dimers, native PAGE was performed [23] . The nuclear extracts (10 mg) were separated using a 7.5% non-denaturing gel (Bio-Rad, Hercules, CA, USA). The samples in the gel were electrophoresed at 25 mA for 60 min after pre-running (at 40 mA for 30 min).
The gel was soaked in SDS electrophoresis buffer (25 mM Tris pH 8.3, 250 mM glycine, 0.1% SDS) for 60 min at room temperature. The gel was transferred to PVDF membrane and analysed by standard Western blot protocol. Densitometry was performed with the Versadoc software (Bio-Rad, Hercules, CA, USA).
Reporter gene assays pGL3-mouse IFN-b promoter construct was a generous gift from Dr Taniguchi (University of Tokyo, Japan) and pGL3-mouse IP-10 promoter construct was a kind gift from Dr Bhat (Medical University of South Carolina, USA). Seventy-two hours after siRNA transfection, 4 Â 10 5 FLS were transfected with 2 mg of reporter plasmid DNA and 0.2 mg of Renilla reniformis luciferase construct as internal control (a gift from Dr David, University of California San Diego, USA). Eighteen hours after transfection, the cells were stimulated with 20 mg/ml poly(I:C). Luciferase activity was measured after 24 h using a dual luciferase assay kit (Promega, Madison, WI, USA).
Measurement of mRNA stability WT FLS were transfected with TBK1 or sc control siRNA for 48 h, after which the cells were serum starved with 0.1% FCS/DMEM for 24 h. FLS were stimulated with 20 mg/ml poly(I:C) for 6 h and then incubated with 10 mg/ml actinomycin D for 0 (t 0 ), 2, 4 and 18 h. Total RNA was isolated and IP-10 mRNA was quantified by quantitative real-time PCR and normalized to b-actin.
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The data are expressed as a percentage of mRNA at t 0 . Control untransfected WT FLS (WT NT) were used as control.
Statistical analysis
Data are expressed as mean (S.E.M.). Comparisons between two groups were performed using Student's t-test, unless otherwise stated. A comparison was considered statistically significant if P < 0.05.
Results
TBK1-and IKKe-deficient cells
To evaluate the functions of TBK1 and IKKe, especially as it relates to IP-10 expression and activation of the IRF pathway, we initially used siRNA to knock down the respective genes. As shown in Fig. 1 , TBK1 expression decreased 72 h after transfection with TBK1 siRNA, but not with sc negative control siRNA. IKKe expression could not be decreased sufficiently by IKKe-specific siRNA in the activated cells (data not shown), most likely due to markedly increased expression as previously described [24] . Since TBK1 deficiency in mice is embryonic lethal [25] , we used siRNA to decrease TBK1 expression and IKKe À/À FLS to evaluate the role of IKKe. TBK1 siRNA decreased TBK1 expression in IKKe À/À FLS (data not shown) and was used to evaluate combined IKKe/TBK1 deficiency.
Poly(I:C)-induced IRF gene expression in TBK1-and IKKe-deficient FLS
IRF3 and IRF7 are critical transcription factors that regulate of TLR3-induced IFN response genes and signalling downstream of the IKK-related kinases [26, 27] . While IRF3 function is generally regulated by post-translational phosphorylation, IRF7 is an inducible gene. Initial studies were performed to determine whether TBK1 and IKKe play a role in the expression of these IRFs ( Fig. 2A) . WT and IKKe À/À cells transfected with TBK1 siRNA or sc control were assayed for IRF3 and IRF7 gene expression by quantitative PCR (qPCR). TBK1-or IKKe-deficient cells or combined deficiency had no significant effect on IRF3 gene expression in resting or poly(I:C)-stimulated cells. IRF7 expression, however, was significantly increased by poly(I:C) in WT and IKKe À/À FLS compared with medium (P = 0.02, n = 3/group). TBK1 deficiency, but not IKKe deficiency, prevented IRF7 induction (P = 0.003). Therefore, poly(I:C)-mediated induction of IRF7, but not IRF3, requires TBK1 in FLS.
FIG. 2 Effect of TBK1 and IKKe deficiency on IRF expression and activation. (A) WT and IKKe
À/À FLS transfected with TBK1 siRNA were stimulated with 20 mg/ml poly(I:C) for 24 h and total RNA was isolated. IRF3 and IRF7 gene expression was determined by qPCR and normalized to HPRT. IRF7 expression was significantly decreased in TBK1-deficient FLS, regardless of IKKe deficiency (*P < 0.04, n = 3 lines/group). IRF3 expression was not altered by the lack of TBK1 or IKKe. (B) TBK1-deficient WT and IKKe À/À FLS were treated for 2 h with poly(I:C) (20 mg/ml) and nuclear extracts were prepared. Native PAGE and western blot analysis were performed using anti-IRF3 antibody. IRF3 monomeric and dimeric forms ( ). IRF3 dimerization was inhibited in TBK1-deficient WT and IKKe À/À cells, indicating that both kinases regulate IRF3 activation in FLS. The figure is representative of three separate experiments. Regulation of IRF3 activation in FLS Poly(I:C) stimulation leads to phosphorylation of IRF3, which dimerizes and functions as a transcription factor for IFN response genes such as IFN-b. Our previous studies suggested that IKKe deficiency can decrease IRF3 phosphorylation in human FLS [24] . The next step in IFN response gene expression is IRF3 dimerization. The contribution of TBK1 and IKKe to poly(I:C)-induced IRF3 dimerization and nuclear translocation was analysed in nuclear extracts of TBK1-deficient WT and IKKe À/À FLS by native gel electrophoresis. Figure 2B shows that IRF3 dimer formation occurred within 2 h of poly(I:C) stimulation. TBK1 deficiency significantly decreased the level of nuclear IRF3 dimers in both WT and IKKe À/À FLS (45 and 41%, respectively). IRF3 dimerization was also decreased by 32% in IKKe À/À FLS.
TBK1-dependent gene expression in synoviocytes IRF3 and IRF7 function as transcription factors along with nuclear factor k-light-chain enhancer of activated B cells (NF-kB) and activator protein-1 to initiate transcription of inflammatory mediators. Since TBK1 regulates IRF7 expression and IRF3 dimerization, we determined whether it alters expression of prototypical IFN response genes in synoviocytes. TBK1-deficient WT and IKKe À/À FLS were stimulated with poly(I:C) and cytokine gene expression was assayed by qPCR (Fig. 3) . IFN-gene expression peaked within 2 h of poly(I:C) stimulation in WT FLS and decreased to baseline levels by 6 h. TBK1 deficiency in both WT and IKKe 
TBK1-dependent cytokine profile in FLS
As noted above, TBK1 is the primary IKK-related kinase required for IFN-and IP-10 gene expression in FLS stimulated with a TLR3 ligand. Previous studies show that IP-10 protein expression can be induced by overexpression of IKKe in human embryonic kidney cells [28] , while others observed an inhibition of IP-10 production in TBK1-deficient MEFs stimulated with poly(I:C) [29] . To evaluate the contribution of TBK1 to IP-10 production in FLS, we evaluated the cytokine profiles in TBK1-deficient WT and IKKe À/À FLS using multiplex analysis of the 24 h culture supernatants (Fig. 4) . IP-10 levels were significantly reduced in Role of TBK1 in IP-10 mRNA stability Our data show that TBK1 regulates IP-10 transcription in synoviocytes. Recent studies, however, indicate that IP-10 expression can also be regulated posttranscriptionally via the degradation of the AU-rich 3 00 -untranslated region (UTR) [30, 31] . Therefore, we evaluated whether TBK1 deficiency also alters IP-10 mRNA stability in poly(I:C)-stimulated FLS. IP-10 mRNA half-life in untransfected WT cells was $16 h (Fig. 5B) . Although there was a trend towards slightly faster decay in TBK1-deficient cells, it did not reach statistical significance.
Discussion
Innate immunity participates in the pathogenesis of numerous inflammatory diseases. For instance, IFN signatures have been demonstrated in the blood and tissues of patients with diverse diseases such as SLE, scleroderma and RA [5] . Innate immune response contributes to adaptive immune responses and potentially to a breakdown in tolerance [32] . While the stimuli that activate innate immunity in RA are uncertain, co-expression and activation of TLRs by endogenous ligands in the synovium is one possible mechanism. Bacterial DNA, peptidoglycan and endogenous ligands such as necrotic debris and   FIG. 4 TBK1-dependent cytokine profile in FLS. WT and IKKe À/À FLS were transfected with TBK1 siRNA and stimulated for 24 h with poly(I:C). Cytokines in the culture supernatants were measured using multiplex analysis. IP-10 and IFN-b protein expression was significantly reduced in TBK1-knockdown FLS (*P < 0.05, n = 3 lines/ group). stress-induced proteins (high mobility group protein B1) [33] are present in the inflamed joint and can activate local TLR2, TLR4 and TLR3. Cultured synoviocytes also express these receptors and can be activated by the same ligands in vitro to produce pro-inflammatory mediators that contribute to joint destruction.
The effects of poly(I:C) on synoviocyte function are rapid and dramatic and trigger a cascade of signalling events leading to the activation of IKKs and IKK-related kinases (IKKe and TBK1, Fig. 6 ). These, in turn, phosphorylate transcription factors such as the IRFs that increase expression of key genes, such as IP-10, that are involved in chronic inflammation. IP-10 plays a critical role in recruiting activated T cells and macrophages into RA synovium and contributes to bone erosion by enhancing osteoclastogenesis [34] . Inhibition of IP-10 function significantly attenuated bone loss in CIA [35] . Clinical studies demonstrating the efficacy of IP-10 neutralization in RA suggest that TBK1 or IKKe might also be potential therapeutic targets. www.rheumatology.oxfordjournals.org TBK1 and IKKe are homologous proteins with overlapping, non-redundant functions since IKKe À/À mice are viable and healthy [36] , while TBK1 deficiency is embryonic lethal [25] . Mouse and human TBK1 proteins share >99% homology, indicating that this protein is highly conserved in mammals. In humans, TBK1 is constitutively and ubiquitously expressed in lymphoid organs such as peripheral blood lymphocytes and spleen as well as in non-lymphoid organs such as brain, kidney and skeletal muscle [37] . In contrast, IKKe is expressed at low basal levels in immune cells as well as synoviocytes, but is rapidly induced in response to TLR activation. The goals of this study were to evaluate the function of the two IKK-related kinases in regulating FLS biology and determine whether either kinase is particularly attractive as a target for modulating a promising chemokine such as IP-10.
The function of TBK1 and IKKe in the TLR3 signalling pathway was evaluated using IKKe À/À and TBK1 knockdown FLS stimulated with poly(I:C). We first examined the effects of TBK1 or IKKe deficiency on IRF3 and IRF7 gene expression. While IRF3 is constitutively expressed in synoviocytes, IRF7 expression is low at basal conditions, but is induced within 24 h. In contrast, plasmacytoid dendritic cells constitutively express IRF7, demonstrating the cell specificity of the function of IKK-related kinases [27] . TBK1 is the primary regulator of IRF7 expression in FLS while neither IKK-related kinase affected IRF3 gene expression.
Phosphorylation of IRF3 causes its dimerization and translocation into the nucleus. In FLS, optimal IRF3 dimerization requires TBK1 as well as IKKe. This observation is consistent with previous reports demonstrating impaired poly(I:C)-mediated IRF3 activation in TBK1 À/À murine embryonic fibroblasts (MEFs) [29] . In contrast, IRF3 activation is completely abolished in TBK1 À/À IKKe À/À double knockout MEFs [38] . IFN-and IP-10 gene and protein expression required TBK1, which is similar to TBK1 À/À MEFs stimulated with either poly(I:C), lipopolysaccharide (LPS) or single-stranded RNA viruses [29] . Interestingly, although IRF3 dimerization was inhibited in IKKe À/À FLS, IFN-b and IP-10 gene or protein expression remained unaltered in these cells.
Activation of TBK1 and IKKe in FLS results in the rapid transcription of primary response genes such as IFN-b, which binds to the IFN-a receptor (IFNaR) in an autocrine manner. The IFNaR triggers activation of the Janus kinase-signal transducers and activators of transcription signalling cascade leading to the production of multiple IFN-b-dependent secondary response genes such as IP-10 and IFN-a. IP-10 can activate FLS in an autocrine manner by binding CXCR3, which is constitutively expressed on the cell surface [11] . The secondary response cytokine production varies with cell lineage since plasmacytoid dendritic cells, MEFs and macrophages produce IFN-a, but FLS do not (data not published) [27, 39] .
We then defined the contribution of TBK1 in the poly(I:C)-induced cytokine response in FLS. TBK1 was required for IFN-b and IP-10 gene as well as protein expression, which is similar to TBK1 À/À MEFs stimulated with either poly(I:C), LPS or single-stranded RNA viruses [29] . Expression of the NF-kB target gene, KC (mouse IL-8 homologue), was not inhibited in TBK1-deficient FLS, suggesting a preservation of NF-kB activity in the absence of TBK1. This contrasts with studies showing inhibition of p65/RelA phosphorylation in TBK1 À/À and IKKe À/À MEFs [15] . Unlike TBK1, IKKe does not regulate IP-10 production in FLS, which differs from other cell lineages that over-express IKKe [28] . We next determined whether IP-10 expression is regulated by post-transcriptional mechanisms in TBK1-deficient FLS. Our data show that TBK1 deficiency does not alter IP-10 mRNA stability in FLS. Therefore, TBK1 deficiency decreases IP-10 expression primarily by inhibiting transcription in FLS. Furthermore, we found no cytoplasmic vesicles with pre-formed IP-10, which would have suggested posttranslational regulation of this chemokine in FLS.
Conclusions
Recent research on TLR biology and IFN response genes has identified new targets for inflammatory and autoimmune diseases. The contribution of IKK-related kinase signalling and IFN signatures to RA pathogenesis suggests that these kinases might be useful therapeutic targets. Based on the profiles of the two kinases, especially as it pertains to IP-10, TBK1 might be more relevant than IKKe as a key contributor to the pathogenesis of the disease.
Rheumatology key messages
. Innate immunity contributes to RA by inducing pro-inflammatory mediators such as IP-10, which mediate joint destruction. . Poly(I:C)-induced IP-10 expression was dependent on TBK1 but not IKKe. . TBK1 is a potential therapeutic target in RA.
